VistaGen: Creating A New, Different Kind Of Antidepressant - Seeking Alpha

Press TelegraphVistaGen: Creating A New, Different Kind Of AntidepressantSeeking AlphaSan Francisco-based Vistagen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing a new drug to treat depression more safely and effectively than traditional drugs. The drug, AV-101, is in a Phase 2 clinical study ...Could Vistagen Therapeutics Incorporated (NASDAQ:VTGN) Skyrocket? The Stock Had Too Little SellersWeeklyHuball 4 news articles »